论文部分内容阅读
目的探讨α-2b干扰素用于慢性丙型肝炎治疗中的效果。方法 40例慢性丙型肝炎患者,随机分为对照组和和治疗组,各20例,对照组采用门冬氨酸、维他命C进行治疗,而治疗组则服用重组人干扰素α-2b注射液进行治疗,与此同时还要口服利巴韦林片进行辅助治疗,两组患者均治疗2个疗程后观察患者血清中的HCV-RNA、抗-HCV以及外周血单个核细胞内HCV-RNA的指标情况。结果治疗结束后,治疗组观察患者血清中的HCV-RNA、抗-HCV以及外周血单个核细胞内HCVRNA的指标的转阴率均高于对照组,差异具有统计学意义(P<0.05)。治疗组部分患者出现头痛、发热等感冒症状,但经过对症处理感冒症状消除,无其他不良反应。结论α-2b干扰素用于慢性丙型肝炎治疗中疗效显著,优于常规治疗方法 ,安全可靠,值得临床推广应用。
Objective To investigate the effect of α-2b interferon on chronic hepatitis C treatment. Methods Forty patients with chronic hepatitis C were randomly divided into control group and treatment group, 20 cases in each group. The control group was treated with aspartic acid and vitamin C. The treatment group received recombinant human interferon α-2b injection Treatment, at the same time also oral ribavirin tablets for adjuvant therapy, two groups of patients were treated for 2 courses of observation after the patient’s serum HCV-RNA, anti-HCV and HCV-RNA in peripheral blood mononuclear cells Indicator situation. Results After treatment, HCV-RNA, anti-HCV and serum HCVRNA in peripheral blood mononuclear cells in the treatment group were significantly lower than those in the control group (P <0.05). Some patients in the treatment group had headache, fever and other symptoms of cold, but after symptomatic treatment of cold symptoms were eliminated, no other adverse reactions. Conclusion α-2b interferon is effective in the treatment of chronic hepatitis C, which is superior to conventional treatment and safe and reliable, which is worthy of clinical application.